Progenics Pharmaceuticals (PGNX) is a biopharmaceutical company focusing on the development and commercialization of therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. The stock is trading up 5.8% at $10.40 in recent trading.
Today's Volume: 100,000Average Volume: 113,794 Volume % Change: 100% >>5 Stocks to Trade for Breakout Gains From a technical perspective, PGNX is ripping higher today on decent volume, and this stock is flirting with a major breakout trade. That trade will hit once PGNX takes out its 52-week high of $10.50 with high-volume. Keep in mind that the last time PGNX traded above $11 a share is back in 2008. Traders should now look for long-biased trades in PGNX if it can sustain a move or close above $10.50 with volume that's near or well above 113,794 shares. If we get that action today or soon, then PGNX could start a bigger trend toward $15.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts